|
Match
|
Document |
Document Title |
|
|
US20150164832 |
GASTRIC RETENTIVE DOSAGE FORMS FOR EXTENDED RELEASE OF ACAMPROSATE INTO THE UPPER GASTROINTESTINAL TRACT
Gastric retentive dosage forms for sustained release of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol... |
|
|
US20120077878 |
GASTRIC RETENTIVE DOSAGE FORMS FOR EXTENDED RELEASE OF ACAMPROSATE INTO THE UPPER GASTROINTESTINAL TRACT
Gastric retentive dosage forms for sustained release of acamprosate are described which may allow once- or twice-daily dosing for both acute and long-term treatment of a disorder including alcohol... |
|
|
US20110034519 |
NUTRITIONAL SUPPLEMENTS
A process for improving the health of a subject, the process comprising orally administering a composition comprising hydroxytyrosol to the subject to provide the subject with a daily dose of... |
|
|
US20150119383 |
ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other... |
|
|
US20130143867 |
ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other... |
|
|
US20130296434 |
FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS
Methods, formulations, and compositions for the treatment of amyloidosis are described. |
|
|
US20120270939 |
FORMULATIONS AND METHODS FOR TREATING AMYLOIDOSIS
Methods, formulations, and compositions for the treatment of amyloidosis are described. |
|
|
US20130085182 |
SODIUM 2-MERCAPTOETHANE SULFONATE FOR USE IN THE TREATMENT OF LUMBAR PAIN
The present invention refers to 2-mercaptoethane sulfonate or pharmaceutically acceptable salts thereof and to pharmaceutical compositions comprising it for epidural use in the treatment of lumbar... |
|
|
US20150209312 |
MODULATION SAPP, SAAP ALPHA AND BDNF LEVELS IN INDIVIDUALS DIAGNOSED WITH FXS AND ASD
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting... |
|
|
US20120020881 |
Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
This invention relates to novel compounds suitable for labeling by positron emitting isotopes, such as 18F, 11C, 13N and 15O, through appropriate labeling reagents, such as 18F reagents and... |
|
|
US20140140948 |
METHOD OF KILLING BEDBUG EGGS
The present invention relates to a method of pre-rinsing laundry and treating other surfaces employing a composition that can kill bedbug eggs. The composition includes an anionic compound and is... |
|
|
US20140073694 |
CYSTAMINE ANALOGUES FOR THE TREATMENT OF PARKINSON'S DISEASE
The present invention relates to the use of cystamine analogues for the treatment of Parkinson's disease. The present invention also relates to the use of composition comprising cystamine... |
|
|
US20110293582 |
METHODS FOR ENHANCING HEMATOPOIETIC STEM/PROGENITOR CELL ENGRAFTMENT
Described herein are methods for enhancing engraftment of hematopoietic stem and progenitor cells using farnesyl compounds identified using a zebrafish model of hematopoietic cell engraftment. The... |
|
|
US20130165521 |
TREATMENT OF FUNGAL INFECTIONS
The present disclosure relates to compositions comprising formic acid as an active ingredient and a softening agent or emollient for use in the treatment of fungal infections of the skin and/or... |
|
|
US20110158980 |
METHODS TO TREAT AND SCREEN FOR AGENTS TO TREAT OBESITY
Described herein are methods for treating obesity or promoting weight loss using agents that alter pyruvate flux in an adipocyte. Methods are provided for administering an agent or combination of... |
|
|
US20110138888 |
TREATMENT OF OBESITY
The present disclosure relates to the treatment, e.g. reduction, of body fat mass levels for example in overweight and obese subjects. The present disclosure also relates to weight control in a... |
|
|
US20120277245 |
Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion
A method of treating cancer or inhibiting metastasis in a subject by increasing intratumoral extracellular pH is presented. The method includes administering to the subject a therapeutically... |
|
|
US20130251858 |
COMPOSITION
The invention relates to acidified cocoa nibs, wherein the nibs comprise at least 20 mg/g of polyphenols, preferably more than 30 mg/g of polyphenols, most preferably from 40 to 60 mg/g of... |
|
|
US20110172171 |
TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA
The present invention relates to taurine or taurine-like substances for the prevention of brain oedema, particularly brain intramyelinic oedema and more particularly brain intramyelinic oedema... |
|
|
US20110319790 |
PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES
Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition... |
|
|
US20150246044 |
NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
The present invention relates to compositions and methods for the treatment of Parkinson's disease and related disorders. More specifically, the present invention relates to novel combinatorial... |
|
|
US20110077239 |
GLYCINE RECEPTOR AGONISTS FOR THE TREATMENT OF PHANTOM PHENOMENA
A medicament for the treatment of the phantom phenomena of acute tinnitus and/or phantom pain, a method for the production of such a medicament, and a method for the treatment of such phantom... |
|
|
US20110076312 |
ANTIMICROBIAL/ANTIBACTERIAL MEDICAL DEVICES COATED WITH TRADITIONAL CHINESE MEDICINES
An antimicrobial composition for coating a medical device. The antimicrobial composition includes a polymeric film forming material and an antimicrobial agent comprising a material selected from... |
|
|
US20130004589 |
DIVALENT CATION/ANION PAIR CONTAINING COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING ENZYMATIC IRRITATION
Compositions and methods for treating and/or preventing conditions such as diaper rash and atopic dermatitis are disclosed. The compositions and methods are particularly useful in the treatment... |
|
|
US20130302389 |
COSMETIC COMPOSITION CONTAINING AT LEAST TWO OSMOLYTES WITH A MOISTURIZING OR ANTIAGING EFFECT
The present invention relates to a cosmetic composition, which comprises a combination of at least two osmolytes chosen from the group comprising taurine or a derivative thereof, inositol, betaine... |
|
|
US20110014192 |
SUPPRESSION OF CANCER GROWTH AND METASTASIS USING NORDIHYDROGUAIARETIC ACID DERIVATIVES WITH METABOLIC MODULATORS
Disclosed is a composition comprising a derivative of NDGA and at least one metabolic modulator. The composition can be in a unit dose form or kit. The composition can comprise at least two... |
|
|
US20120202883 |
EFFECTS OF IDH1 AND IDH2 MUTATIONS ON THE CELLULAR METABOLOME
Point mutations of the NADP+-dependent isocitrate dehydrogenases (IDH1 and IDH2) occur early in the pathogenesis of gliomas. When mutated, IDH1 and IDH2 gain the ability to produce the metabolite... |
|
|
US20110033438 |
Method and pharmacological composition for the diagnosis and treatment of male
Pharmaceutical compositions for treating male sub-fertility that include an agent that causes a reduction in an effect of extracellular DNA on sperm cells, are provided. The agent may be, for... |
|
|
US20080058421 |
COMPOSITIONS FOR CLEANING AND DISINFECTING NASAL TRACT AND SINUS CAVITY
Biodegradable compositions for cleaning and disinfecting nasal tract and sinus cavity using food additive ingredients or ingredients that are safe. |
|
|
US20120282351 |
System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino Acids
Disclosed is a system that prevents the development of infection and biofilm establishment in medical devices in general, and in particular Urinary Tract Infections (UTI), including... |
|
|
US20110003860 |
HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as,... |
|
|
US20130121985 |
METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF MALE SUB-FERTILITY
Methods for treating male sub-fertility by administering a pharmaceutical composition to a subject in need thereof are provided. The pharmaceutical compositions include an agent that causes a... |
|
|
US20110110913 |
PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHODS OF USE THEREOF FOR TREATING CELL DISORDERS
A method of inducing NAD+ synthesis in a subject. The method comprises administering to the subject a therapeutically effective amount of resveratrol or a functionally equivalent analogue or... |
|
|
US20080044455 |
Tonsillitus Treatment
A therapeutic agent and methodology for treatment of tonsillitis and tonsil, throat and mouth infection is provided as a combination of Lactic Acid and a delivery vehicle, such as an ingestible... |
|
|
US20110159304 |
ANTI-SULPHATE REDUCING BACTERIA COMPOSITION COMPRISING 1,2-BENZISOTHIAZOL-3(2H)-ONE, IRGASAN, BENZYL-2-BROMOACETATE, 2,2-DIBROMO-2-CYANOACETAMIDE, AND 2-BROMO-2-NITROPROPAN-1,3-DIOL
Disclosed are a composition for inhibiting a proliferation of sulphate reducing bacteria comprising at least one of 1,2-benzisothiazol-3(2H)-one, irgasan, benzyl-2-bromoacetate,... |
|
|
US20110182953 |
POLYMORPHIC FORM OF CALCIUM ACAMPROSATE
The present invention relates to a new polymorphic form of calcium acetyl-homotaurinate, designated as form B, and processes for the preparation of said form B and of the known crystalline form. |
|
|
US20100272783 |
Methods of Treating Infections of the Nail
Disclosed herein are compositions and methods of treating or preventing an infection of the nail, claw, or hoof comprising administering to a subject a pharmaceutical composition comprising an... |
|
|
US20120074014 |
PRODUCT TYPICALLY BASED ON SALT OF PEROXYMONOSULFURIC ACID AND SUITABLE FOR MEDICINAL USAGE, AND ASSOCIATED PRODUCT FABRICATION
Products based on salt of peroxymonosulfuric acid are suitable for treating or/and preventing diseases and other debilitating medical conditions caused by bacterial, eukaryotic, prion, and viral... |
|
|
US20150174199 |
GLUTEN-RELATED DISORDERS
The present invention features compositions and methods for treating gluten-related disorders. We describe compositions comprising one or more metabolites produced by Lactobacillus paracasei CBA... |
|
|
US20110237676 |
SPERMICIDAL AND MICROBICIDAL COMPOSITIONS
Provided herein are new spermicidal compositions that include one or more fluorous surfactants, e.g., non-ionic fluorous surfactants, anionic fluorous surfactants, cationic fluorous surfactants,... |
|
|
US20110196014 |
METHIONINE ANALOGS AND METHODS OF USING SAME
Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit... |
|
|
US20110003689 |
USE OF POLYMERIC GUANIDINE DERIVATIVES FOR THE CONTROL OF UNWANTED MICROORGANISMS IN CROP PROTECTION
The present invention relates to the use of polymeric guanidine derivatives for the curative and/or preventive treatment of unwanted microorganisms such as bacteria and phytopathogenic fungi in... |
|
|
US20130123358 |
Metabolic Benefits to Butyrate as a Chronic Diet Supplement
Sodium butyrate was chronically administrated through diet supplementation at 5% w/w in a high fat diet. Supplementation of butyrate prevented development of insulin resistance and obesity in... |
|
|
US20110151025 |
Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
Disclosed herein are methods and compositions for the treatment or prophylaxis, in a mammal, of bronchopulmonary infections, obstructive pulmonary disease, cystic fibrosis, and... |
|
|
US20140309273 |
COMPOUNDS AND METHODS OF TREATING OBESITY
Provided are new fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, e.g., as agents... |
|
|
US20120315298 |
LOCAL TREATMENT OF NEUROFIBROMAS
A method for treating a neurofibroma, e.g. dermal neurofibroma, a subdermal neurofibroma, or a superficial plexiform neurofibroma, in a subject in need of such treatment is disclosed. The method... |
|
|
US20100028823 |
Anti-microbial orthodontic compositions and appliances and methods of production and use thereof
The presently disclosed and claimed invention is directed to anti-microbial orthodontic apparatus and anti-microbial orthodontic compositions comprising an effective amount of a selenium compound,... |
|
|
US20080213202 |
Composition For Improving Skin Lipid Barrier Function
The invention relates to a composition for topical application to the skin comprising effective amounts of a protease inhibitor and a cell differentiation enhancer. The composition is useful in... |
|
|
US20140350113 |
CD4-MIMETIC INHIBITORS OF HIV-1 ENTRY AND METHODS OF USE THEREOF
Described herein are small-molecule mimics of CD4, which both enter the Phe43 cavity and target Asp368 of gp120, the HIV-1 envelope protein. Also described herein are methods of using these... |
|
|
US20120328519 |
DENTRIC POLYGLYCEROL SULFATES AND SULFONATES AND THEIR USE FOR INFLAMMATORY DISEASES
The present invention relates to the novel compound classes of dendritic polyglycerol sulfates and sultanates as well as to their production and use for the treatment of diseases, particularly... |